PRTODAY / NewswireToday Free press release distribution service network

More news: Research
Written by / Agency / Source: Veeda Clinical Research Ltd

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Veeda Oncology Announces New Service Line for Community-Based Oncology Practices - Veeda Oncology, a full service Oncology CRO with headquarters in Columbus, Ohio, has launched a valued new service line as part of its Site Management Services (SMO), Virtual Research Management (VRM), for community-based oncology practices
Veeda Oncology Announces New Service Line for Community-Based Oncology Practices

 

NewswireToday - /newswire/ - Ahmedabad, Gujarat, India, 2011/05/18 - Veeda Oncology, a full service Oncology CRO with headquarters in Columbus, Ohio, has launched a valued new service line as part of its Site Management Services (SMO), Virtual Research Management (VRM), for community-based oncology practices.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Research Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Virtual Research Management is a program that will provide management services to community-based oncology practices to enhance research program success. These services are individualized based on Veeda’s initial assessment of needs in collaboration with the practice preferences in areas such as strategic and financial planning, and operational support. By providing additional tools and resources, our services are meant to supplement current research programs in areas of existing need. This program has been successfully piloted at several community-based sites.

Sharon Jameson, BSN, MBA, Vice President, Clinical Development and Operations for the Veeda Oncology’s site management organization (SMO), stated,“Community based practices face many challenges in conducting oncology clinical trials in today’s economic environment. The primary challenges are meeting accrual goals while maintaining economic stability of the research program”.

“Veeda Oncology’s Research Management program has definitely elevated our ability to manage our research program both operationally and financially.” Administrator, NM practice

Veeda Oncology is a global Oncology CRO with operations in the US, Eastern/Western Europe and India. The company is a full service Oncology CRO for Phase I through Phase IV studies with the unique capability of providing rapid and strong global patient accrual with an effective cost structure.

Veeda Oncology (veedaoncology.com) is part of the Veeda Group (veedacr.com) that includes Veeda Clinical Research (Veeda CR), which is a leading CRO specializing in the early clinical development of drugs. With state of the art clinical pharmacology units in the UK, Europe and India, fully accredited GLP Laboratories and an established Biometrics team in Belgium and India, Veeda CR is able to offer clients a full range of Phase I-IIa services.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Research Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: Veeda Clinical Research Ltd

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 
 
  Your Banner Ad showing on ALL
Research articles,
CATCH Visitors via Your Competitors Announcements!


Veeda Oncology Announces New Service Line for Community-Based Oncology Practices

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

|
Publisher Contact: Jilmil Joshi - VeedaCR.com 
jilmil.joshi[.]veedacr.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Veeda Clinical Research Ltd securities in any jurisdiction including any other companies listed or named in this release.

Research via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From Veeda Clinical Research Ltd / Company Profile


Read Research Most Recent Related Newswires:

DSM Highlights Health and Wellness Solutions for All At Gulfood Manufacturing 2017
DSM Announces Partnership with Cerapedics to Develop and Manufacture Next Generation of Peptide Enhanced Bone Graft
DSM Announces Somos® Distribution Agreement with RP America
Thales Selects Canada as New Global Hub to Boost Artificial Intelligence Expertise
DSM High-temperature Plastics Successfully Replace Metal in Charge Air Cooler End Cap Application
DSM Developing Novel Materials Solution for High-pressure Composite Tanks for Hydrogen Storage
DSM Brings Digestive Comfort to Gluten Sensitive Adults with Launch of Unique Enzyme
DSM Announces Exclusive Partnership with Nanjing Cosmos Chemical Co., Ltd and Plans to Continue Expansion in UV Filters
DSM Launches New Enzyme Solutions At IFT17 to Improve Softness and Moistness of Gluten-free Bread
DSM and Evonik Select Nebraska for Production of Breakthrough Omega-3
Phasor to Develop Next Generation Electronically Steerable Antenna Featuring DSM Dyneema’s Advanced Radome Solution
DSM’s Delvotest® T Antibiotic Residue Test for Milk Validated by Finnish Food Safety Authority
Royal DSM to Make Equity Investment in Amyris with the Purpose of Establishing A Long-term Relationship
DSM Unveils New Beauty Active At NYSCC Suppliers’ Day
Iridea Bio - A New Sustainable Paint Made with DSM’s Decovery® Plant-based Resin

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  La Bella Bakery Artisan Bakery Arizona

Visit  BizJobs.com





 
  ©2017 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)